<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00892619</url>
  </required_header>
  <id_info>
    <org_study_id>h-22378</org_study_id>
    <nct_id>NCT00892619</nct_id>
  </id_info>
  <brief_title>Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel</brief_title>
  <official_title>Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Debakey Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Michael Debakey Veterans Affairs Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epiretinal membranes (ERM) are cellular membranes on the surface of the retina that result in
      distortion of the vision (metamorphopsia), and decreased best-corrected visual acuity. They
      are most frequently found in patients over the age of 50 and have a reported prevalence of
      7-12%. [1,2] Epiretinal membranes are caused by posterior vitreous separation, retinal
      detachment, proliferative vitreoretinopathy, cataract surgery, trauma, inflammation, retinal
      vascular disease, and idiopathic. [1-4] Epiretinal membrane removal by pars plana vitrectomy
      combined with internal limiting membrane peeling leads to improved vision, decreased
      metamorphopsia, and improved quality of life after surgery. [2] Internal limiting membrane
      (ILM) peel has been associated with decreased rates of epiretinal membrane recurrence and is
      also performed during vitrectomy for repair of macular holes or vitreomacular traction. [5,6]
      Internal limiting membrane peeling can be performed by using an instrument to make a break in
      the membrane followed by peeling with forceps, or by utilizing ILM forceps alone to pinch and
      peel an unviolated ILM. No study exists comparing different intraoperative techniques used
      for ILM peeling on visual outcomes and operating time. The investigators hypothesize that
      using a &quot;pinch and peel&quot; technique will equal outcomes with shorter operating time than other
      techniques.

        1. McDonald HR, Johnson RN, Ai E, Jumper JM, Fu AD. Macular epiretinal membranes. Retina,
           4th edition, editor Ryan SJ, Wilkinson CP, 2006, p 2509-2525.

        2. Ghazi-Nouri SM, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Vitrectomy and epiretinal
           membrane peel surgery visual function and quality of life following. 2006;90;559-562;
           Br. J. Ophthalmol

        3. Haritoglu C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. The Effect of
           Indocyanine-Green on Functional Outcome of Macular Pucker Surgery. AM. J. Ophthal. VOL.
           135,NO.3, 328-337, Mar 2003

        4. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal
           membranes: an immunohistochemical study. Br. J. Ophthalmol, 1984, 68, 708-715

        5. Park DW, Dugel PU, Garda J, Sipperley JO, Thach A, Sneed SR, Blaisdell J. Macular Pucker
           Removal with and without Internal Limiting Membrane Peeling: Pilot Study. Ophthalmology
           Volume 110, 1, Jan 2003

        6. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting
           membrane peeling. Clinical and Experimental Ophthalmology, 2005, 33:379-385
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual acuity</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in humphrey visual field</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Epiretinal Membrane</condition>
  <condition>Vitreomacular Traction</condition>
  <arm_group>
    <arm_group_label>ILM forceps</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using ILM forceps to initiate and complete peel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using an instrument to create a break in the ILM followed by peeling of the membrane with end-grasping forceps</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>using ILM forceps alone</intervention_name>
    <description>Using ILM forceps to initiate and complete ILM peel</description>
    <arm_group_label>ILM forceps</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Breaking and peeling with end-grasping forceps</intervention_name>
    <description>Using an instrument to create a break in the ILM followed by peeling of the membrane with end-grasping forceps</description>
    <arm_group_label>Other</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Epiretinal membrane with associated macular thickening or cystoid macular edema
             present;

          -  ETDRS best corrected visual acuity 20/50 or worse attributed to the effects of the
             epiretinal membrane;

          -  Pars plana vitrectomy/membrane peel planned for treatment of the epiretinal membrane;

          -  Patients older than 19 years of age;

          -  No co-existent retina pathology or optic neuropathy that may influence the visual
             field.

        Exclusion Criteria:

          -  Patient unwilling or unable to provide informed consent;

          -  Co-existing retina pathology (proliferative diabetic retinopathy, central retinal vein
             occlusion, branch retinal vein occlusion, central/branch retinal artery occlusion, ERM
             secondary to trauma, prior surgery for ERM);

          -  Co-existing lenticular opacity;

          -  Optic neuropathy causing a pre-existing visual field defect involving the central 10
             degrees of vision.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petros E Carvounis, B.M.B.Ch., F.R.C.S.C.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine, Michael Debakey VAMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jordan L Heffez, MD</last_name>
    <phone>713-798-3880</phone>
    <email>heffez@bcm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anita Austin</last_name>
    <phone>713-798-5756</phone>
    <email>aaustin@bcm.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Austin</last_name>
      <phone>713-798-5756</phone>
      <email>aaustin@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Petros E Carvounis, B.M.B.Ch., F.R.C.S.C.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michael Debakey VAMC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Austin</last_name>
      <phone>713-798-5756</phone>
      <email>aaustin@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Petros E Carvounis, B.M.B.Ch., F.R.C.S.C.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordan L Heffez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew J Barkmeier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2009</study_first_submitted>
  <study_first_submitted_qc>April 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2009</study_first_posted>
  <last_update_submitted>April 30, 2009</last_update_submitted>
  <last_update_submitted_qc>April 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>PETROS EUTHYMIOU CARVOUNIS, M.D.</name_title>
    <organization>Baylor College of Medicine, Micheal Debakey Veterans Affairs Medical Center</organization>
  </responsible_party>
  <keyword>Epiretinal Membrane</keyword>
  <keyword>Vitreomacular traction</keyword>
  <keyword>MVR blade</keyword>
  <keyword>Tano brush</keyword>
  <keyword>ILM forceps</keyword>
  <keyword>surgical technique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

